{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:19:57Z","timestamp":1791656397948,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T00:00:00Z","timestamp":1523664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CBRG\/0102\/2016"],"award-info":[{"award-number":["NMRC\/CBRG\/0102\/2016"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CBRG\/0036\/2017"],"award-info":[{"award-number":["NMRC\/CBRG\/0036\/2017"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["R-185-000-285-112"],"award-info":[{"award-number":["R-185-000-285-112"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12035-018-1058-0","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T19:27:02Z","timestamp":1523647622000},"page":"9188-9203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["SIRT2 Inhibition Confers Neuroprotection by Downregulation of FOXO3a and MAPK Signaling Pathways in Ischemic Stroke"],"prefix":"10.1007","volume":"55","author":[{"given":"David T.","family":"She","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lap Jack","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Ha","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiruma V.","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,14]]},"reference":[{"key":"1058_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England) 380:2095\u20132128. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)61728-0","journal-title":"Lancet (London, England)"},{"key":"1058_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neuropharm.2008.01.005","volume":"55","author":"KP Doyle","year":"2008","unstructured":"Doyle KP, Simon RP, Stenzel-Poore MP (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55:310\u2013318. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2008.01.005","journal-title":"Neuropharmacology"},{"key":"1058_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40256-013-0007-6","volume":"13","author":"S Bansal","year":"2013","unstructured":"Bansal S, Sangha KS, Khatri P (2013) Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs 13:57\u201369. \n                    https:\/\/doi.org\/10.1007\/s40256-013-0007-6","journal-title":"Am J Cardiovasc Drugs"},{"key":"1058_CR4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","volume":"79","author":"P Lipton","year":"1999","unstructured":"Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431\u20131568","journal-title":"Physiol Rev"},{"key":"1058_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67:181\u2013198. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2010.07.002","journal-title":"Neuron"},{"key":"1058_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700\u2013714. \n                    https:\/\/doi.org\/10.1038\/nrm2970","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1058_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroscience.2017.10.038","volume":"371","author":"Y Ni","year":"2018","unstructured":"Ni Y, Gu W-W, Liu Z-H, Zhu YM, Rong JG, Kent TA, Li M, Qiao SG et al (2018) RIP1K contributes to neuronal and astrocytic cell death in ischemic stroke via activating autophagic-lysosomal pathway. Neuroscience 371:60\u201374. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2017.10.038","journal-title":"Neuroscience"},{"key":"1058_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L et al (2018) Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ 25:486\u2013541. \n                    https:\/\/doi.org\/10.1038\/s41418-017-0012-4","journal-title":"Cell Death Differ"},{"key":"1058_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00145","volume":"6","author":"SE Aune","year":"2015","unstructured":"Aune SE, Herr DJ, Kutz CJ, Menick DR (2015) Histone deacetylases exert class-specific roles in conditioning the brain and heart against acute ischemic injury. Front Neurol 6:145. \n                    https:\/\/doi.org\/10.3389\/fneur.2015.00145","journal-title":"Front Neurol"},{"key":"1058_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/jcbfm.2013.93","volume":"33","author":"S Schweizer","year":"2013","unstructured":"Schweizer S, Meisel A, M\u00e4rschenz S (2013) Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab 33:1335\u20131346. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2013.93","journal-title":"J Cereb Blood Flow Metab"},{"key":"1058_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12975-017-0544-4","volume":"8","author":"DT She","year":"2017","unstructured":"She DT, Jo D-G, Arumugam TV (2017) Emerging roles of sirtuins in ischemic stroke. Transl Stroke Res 8:405\u2013423. \n                    https:\/\/doi.org\/10.1007\/s12975-017-0544-4","journal-title":"Transl Stroke Res"},{"key":"1058_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253\u2013295. \n                    https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092250","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"1058_CR13","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1073\/pnas.110148297","volume":"97","author":"J Landry","year":"2000","unstructured":"Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R (2000) The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci U S A 97(11):5807\u20135811. \n                    https:\/\/doi.org\/10.1073\/pnas.110148297","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1058_CR14","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.111.246488","volume":"110","author":"MF Oellerich","year":"2012","unstructured":"Oellerich MF, Potente M (2012) FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ Res 110:1238\u20131251. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.246488","journal-title":"Circ Res"},{"key":"1058_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrm1616","volume":"6","author":"L Bordone","year":"2005","unstructured":"Bordone L, Guarente L (2005) Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6:298\u2013305. \n                    https:\/\/doi.org\/10.1038\/nrm1616","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1058_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1097-2765(03)00038-8","volume":"11","author":"BJ North","year":"2003","unstructured":"North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11:437\u2013444","journal-title":"Mol Cell"},{"key":"1058_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/emboj\/20.1.197","volume":"20","author":"S Perrod","year":"2001","unstructured":"Perrod S, Cockell MM, Laroche T, Renauld H, Ducrest AL, Bonnard C, Gasser SM (2001) A cytosolic NAD-dependent deacetylase, Hst2p, can modulate nucleolar and telomeric silencing in yeast. EMBO J 20:197\u2013209. \n                    https:\/\/doi.org\/10.1093\/emboj\/20.1.197","journal-title":"EMBO J"},{"key":"1058_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1101\/gad.1412706","volume":"20","author":"A Vaquero","year":"2006","unstructured":"Vaquero A, Scher MB, Lee DH, Sutton A, Cheng HL, Alt FW, Serrano L, Sternglanz R et al (2006) SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev 20:1256\u20131261. \n                    https:\/\/doi.org\/10.1101\/gad.1412706","journal-title":"Genes Dev"},{"key":"1058_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM et al (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science 317:516\u2013519. \n                    https:\/\/doi.org\/10.1126\/science.1143780","journal-title":"Science"},{"key":"1058_CR20","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","volume":"2","author":"V Chopra","year":"2012","unstructured":"Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, Cipicchio PM, Lauver MA et al (2012) The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington\u2019s disease mouse models. Cell Rep 2:1492\u20131497. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2012.11.001","journal-title":"Cell Rep"},{"key":"1058_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00082","volume":"3","author":"RM Oliveira de","year":"2012","unstructured":"de Oliveira RM, Sarkander J, Kazantsev AG, Outeiro TF (2012) SIRT2 as a therapeutic target for age-related disorders. Front Pharmacol 3:82. \n                    https:\/\/doi.org\/10.3389\/fphar.2012.00082","journal-title":"Front Pharmacol"},{"key":"1058_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ijc.25032","volume":"127","author":"R Deng","year":"2010","unstructured":"Deng R, Tang J, Xie B-F, Feng GK, Huang YH, Liu ZC, Zhu XF (2010) SYUNZ-16, a newly synthesized alkannin derivative, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB\/AKT kinase activity and blockade of AKT\/FOXO signal pathway. Int J Cancer 127:220\u2013229. \n                    https:\/\/doi.org\/10.1002\/ijc.25032","journal-title":"Int J Cancer"},{"key":"1058_CR23","doi-asserted-by":"publisher","first-page":"49795","DOI":"10.1074\/jbc.M309523200","volume":"278","author":"A Sunters","year":"2003","unstructured":"Sunters A, Fern\u00e1ndez de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH et al (2003) FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278:49795\u201349805. \n                    https:\/\/doi.org\/10.1074\/jbc.M309523200","journal-title":"J Biol Chem"},{"key":"1058_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1084\/jem.20060353","volume":"203","author":"H You","year":"2006","unstructured":"You H, Pellegrini M, Tsuchihara K, Yamamoto K, Hacker G, Erlacher M, Villunger A, Mak TW (2006) FOXO3a-dependent regulation of Puma in response to cytokine\/growth factor withdrawal. J Exp Med 203:1657\u20131663. \n                    https:\/\/doi.org\/10.1084\/jem.20060353","journal-title":"J Exp Med"},{"key":"1058_CR25","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/cmi.12298","volume":"16","author":"M Haoues","year":"2014","unstructured":"Haoues M, Refai A, Mallavialle A, Barbouche MR, Laabidi N, Deckert M, Essafi M (2014) Forkhead box O3 (FOXO3) transcription factor mediates apoptosis in BCG-infected macrophages. Cell Microbiol 16:1378\u20131390. \n                    https:\/\/doi.org\/10.1111\/cmi.12298","journal-title":"Cell Microbiol"},{"key":"1058_CR26","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","volume":"23","author":"T Wada","year":"2004","unstructured":"Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838\u20132849. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1207556","journal-title":"Oncogene"},{"key":"1058_CR27","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s12035-017-0394-9","volume":"55","author":"DY-W Fann","year":"2017","unstructured":"Fann DY-W, Lim Y-A, Cheng Y-L, Lok KZ, Chunduri P, Baik SH, Drummond GR, Dheen ST et al (2017) Evidence that NF-\u03baB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke. Mol Neurobiol 55:1082\u20131096. \n                    https:\/\/doi.org\/10.1007\/s12035-017-0394-9","journal-title":"Mol Neurobiol"},{"key":"1058_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.326","volume":"4","author":"DY-W Fann","year":"2013","unstructured":"Fann DY-W, Lee SY, Manzanero S et al (2013) Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis 4:e790. \n                    https:\/\/doi.org\/10.1038\/cddis.2013.326","journal-title":"Cell Death Dis"},{"key":"1058_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jneumeth.2009.12.020","volume":"187","author":"M Kramer","year":"2010","unstructured":"Kramer M, Dang J, Baertling F, Denecke B, Clarner T, Kirsch C, Beyer C, Kipp M (2010) TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J Neurosci Methods 187:84\u201389. \n                    https:\/\/doi.org\/10.1016\/j.jneumeth.2009.12.020","journal-title":"J Neurosci Methods"},{"key":"1058_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1385\/MN:34:3:249","volume":"34","author":"H Zhao","year":"2006","unstructured":"Zhao H, Sapolsky RM, Steinberg GK (2006) Phosphoinositide-3-kinase\/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34:249\u2013270. \n                    https:\/\/doi.org\/10.1385\/MN:34:3:249","journal-title":"Mol Neurobiol"},{"key":"1058_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12031-016-0717-8","volume":"59","author":"J Sun","year":"2016","unstructured":"Sun J, Nan G (2016) The mitogen-activated protein kinase (MAPK) signaling pathway as a discovery target in stroke. J Mol Neurosci 59:90\u201398. \n                    https:\/\/doi.org\/10.1007\/s12031-016-0717-8","journal-title":"J Mol Neurosci"},{"key":"1058_CR32","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1074\/jbc.M113.537266","volume":"289","author":"G Ramakrishnan","year":"2014","unstructured":"Ramakrishnan G, Davaakhuu G, Kaplun L, Chung WC, Rana A, Atfi A, Miele L, Tzivion G (2014) Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin. J Biol Chem 289:6054\u20136066. \n                    https:\/\/doi.org\/10.1074\/jbc.M113.537266","journal-title":"J Biol Chem"},{"key":"1058_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857\u2013868","journal-title":"Cell"},{"key":"1058_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/hep.28777","volume":"65","author":"J Wang","year":"2017","unstructured":"Wang J, Koh H-W, Zhou L, Bae UJ, Lee HS, Bang IH, Ka SO, Oh SH et al (2017) Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1. Hepatology 65:225\u2013236. \n                    https:\/\/doi.org\/10.1002\/hep.28777","journal-title":"Hepatology"},{"key":"1058_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10495-016-1341-3","volume":"22","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mu Y, Zhou X, Ji H, Gao X, Cai WW, Guan Q, Xu T (2017) SIRT2-mediated FOXO3a deacetylation drives its nuclear translocation triggering FasL-induced cell apoptosis during renal ischemia reperfusion. Apoptosis 22:519\u2013530. \n                    https:\/\/doi.org\/10.1007\/s10495-016-1341-3","journal-title":"Apoptosis"},{"key":"1058_CR36","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1007\/s12035-016-0173-z","volume":"54","author":"XQ Xie","year":"2016","unstructured":"Xie XQ, Zhang P, Tian B, Chen XQ (2016) Downregulation of NAD-dependent deacetylase SIRT2 protects mouse brain against ischemic stroke. Mol Neurobiol 54:7251\u20137261. \n                    https:\/\/doi.org\/10.1007\/s12035-016-0173-z","journal-title":"Mol Neurobiol"},{"key":"1058_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.brainres.2010.08.007","volume":"1357","author":"L Zhang","year":"2010","unstructured":"Zhang L, Qu Y, Tang J, Chen D, Fu X, Mao M, Mu D (2010) PI3K\/Akt signaling pathway is required for neuroprotection of thalidomide on hypoxic-ischemic cortical neurons in vitro. Brain Res 1357:157\u2013165. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2010.08.007","journal-title":"Brain Res"},{"key":"1058_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1471-4159.2009.05974.x","volume":"109","author":"Yan Dong","year":"2009","unstructured":"Dong Y, Liu HD, Zhao R, Yang CZ, Chen XQ, Wang XH, Lau LT, Chen J, Yu ACH (2009) Ischemia activates JNK\/c-Jun\/AP-1 pathway to up-regulate 14-3-3gamma in astrocyte. J Neurochem 109 Suppl:182\u20138. doi: \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05974.x\n                    \n                  , 188","journal-title":"Journal of Neurochemistry"},{"key":"1058_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132998","volume":"10","author":"D Li","year":"2015","unstructured":"Li D, Li X, Wu J, Li J, Zhang L, Xiong T, Tang J, Qu Y et al (2015) Involvement of the JNK\/FOXO3a\/Bim pathway in neuronal apoptosis after hypoxic-ischemic brain damage in neonatal rats. PLoS One 10:e0132998. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0132998","journal-title":"PLoS One"},{"key":"1058_CR40","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/jcbfm.2015.123","volume":"35","author":"J Yin","year":"2015","unstructured":"Yin J, Han P, Tang Z, Liu Q, Shi J (2015) Sirtuin 3 mediates neuroprotection of ketones against ischemic stroke. J Cereb Blood Flow Metab 35:1783\u20131789. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2015.123","journal-title":"J Cereb Blood Flow Metab"},{"key":"1058_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139095","volume":"10","author":"J Li","year":"2015","unstructured":"Li J, Flick F, Verheugd P, Carloni P, L\u00fcscher B, Rossetti G (2015) Insight into the mechanism of intramolecular inhibition of the catalytic activity of sirtuin 2 (SIRT2). PLoS One 10:e0139095. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0139095","journal-title":"PLoS One"},{"key":"1058_CR42","first-page":"1187","volume":"27","author":"S Voelter-Mahlknecht","year":"2005","unstructured":"Voelter-Mahlknecht S, Ho AD, Mahlknecht U (2005) FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2). Int J Oncol 27:1187\u20131196","journal-title":"Int J Oncol"},{"key":"1058_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000784","volume":"2","author":"BJ North","year":"2007","unstructured":"North BJ, Verdin E (2007) Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. PLoS One 2:e784. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0000784","journal-title":"PLoS One"},{"key":"1058_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00029","volume":"3","author":"F Flick","year":"2012","unstructured":"Flick F, L\u00fcscher B (2012) Regulation of sirtuin function by posttranslational modifications. Front Pharmacol 3:29. \n                    https:\/\/doi.org\/10.3389\/fphar.2012.00029","journal-title":"Front Pharmacol"},{"key":"1058_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700475","volume":"3","author":"A Fischer","year":"2017","unstructured":"Fischer A, M\u00fchlh\u00e4user WWD, Warscheid B, Radziwill G (2017) Membrane localization of acetylated CNK1 mediates a positive feedback on RAF\/ERK signaling. Sci Adv 3:e1700475. \n                    https:\/\/doi.org\/10.1126\/sciadv.1700475","journal-title":"Sci Adv"},{"key":"1058_CR46","doi-asserted-by":"publisher","first-page":"47928","DOI":"10.1074\/jbc.M207509200","volume":"277","author":"V Modur","year":"2002","unstructured":"Modur V, Nagarajan R, Evers BM, Milbrandt J (2002) FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 277:47928\u201347937. \n                    https:\/\/doi.org\/10.1074\/jbc.M207509200","journal-title":"J Biol Chem"},{"key":"1058_CR47","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2174\/138945011796150316","volume":"12","author":"M Boccitto","year":"2011","unstructured":"Boccitto M, Kalb RG (2011) Regulation of Foxo-dependent transcription by post-translational modifications. Curr Drug Targets 12:1303\u20131310. \n                    https:\/\/doi.org\/10.2174\/138945011796150316","journal-title":"Curr Drug Targets"},{"key":"1058_CR48","doi-asserted-by":"publisher","first-page":"366","DOI":"10.14336\/AD.2014.0500366","volume":"5","author":"A Hafeez","year":"2014","unstructured":"Hafeez A, Elmadhoun O, Peng C et al (2014) Reduced apoptosis by ethanol and its association with PKC-\u03b4 and Akt signaling in ischemic stroke. Aging Dis 5:366\u2013372. \n                    https:\/\/doi.org\/10.14336\/AD.2014.0500366","journal-title":"Aging Dis"},{"key":"1058_CR49","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s12272-011-0620-3","volume":"34","author":"MIH Bhuiyan","year":"2011","unstructured":"Bhuiyan MIH, Jung SY, Kim HJ, Lee YS, Jin C (2011) Major role of the PI3K\/Akt pathway in ischemic tolerance induced by sublethal oxygen-glucose deprivation in cortical neurons in vitro. Arch Pharm Res 34:1023\u20131034. \n                    https:\/\/doi.org\/10.1007\/s12272-011-0620-3","journal-title":"Arch Pharm Res"},{"key":"1058_CR50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0092-8674(00)81883-8","volume":"88","author":"TF Franke","year":"1997","unstructured":"Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88:435\u2013437","journal-title":"Cell"},{"key":"1058_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.69","volume":"5","author":"Q Liu","year":"2014","unstructured":"Liu Q, Qiu J, Liang M, Golinski J, van Leyen K, Jung JE, You Z, Lo EH et al (2014) Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis 5:e1084. \n                    https:\/\/doi.org\/10.1038\/cddis.2014.69","journal-title":"Cell Death Dis"},{"key":"1058_CR52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2443.2010.01460.x","volume":"16","author":"Y Li","year":"2011","unstructured":"Li Y, Matsumori H, Nakayama Y, Osaki M, Kojima H, Kurimasa A, Ito H, Mori S et al (2011) SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 16:34\u201345. \n                    https:\/\/doi.org\/10.1111\/j.1365-2443.2010.01460.x","journal-title":"Genes Cells"},{"key":"1058_CR53","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1038\/onc.2008.301","volume":"27","author":"DN Dhanasekaran","year":"2008","unstructured":"Dhanasekaran DN, Reddy EP (2008) JNK signaling in apoptosis. Oncogene 27:6245\u20136251. \n                    https:\/\/doi.org\/10.1038\/onc.2008.301","journal-title":"Oncogene"},{"key":"1058_CR54","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1242\/jcs.073783","volume":"123","author":"KM Rothgiesser","year":"2010","unstructured":"Rothgiesser KM, Erener S, Waibel S, Luscher B, Hottiger MO (2010) SIRT2 regulates NF-\u03baB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci 123:4251\u20134258. \n                    https:\/\/doi.org\/10.1242\/jcs.073783","journal-title":"J Cell Sci"},{"key":"1058_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00042","volume":"3","author":"TL Spires-Jones","year":"2012","unstructured":"Spires-Jones TL, Fox LM, Rozkalne A, Pitstick R, Carlson GA, Kazantsev AG (2012) Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia. Front Pharmacol 3:42. \n                    https:\/\/doi.org\/10.3389\/fphar.2012.00042","journal-title":"Front Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1058-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1058-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1058-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T19:39:36Z","timestamp":1555184376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1058-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,14]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1058"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1058-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,14]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All studies were performed under research protocol approved by the Institutional Animal Care and Use Committee (IACUC) of National University of Singapore (NUS) in accordance with the National Advisory Committee for Laboratory Animal Research (NACLAR) guidelines. Every effort was made to reduce animal suffering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}